INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 46 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $900,000 | -8.6% | 975,000 | 0.0% | 0.03% | +22.2% |
| Q3 2018 | $985,000 | -24.1% | 975,000 | -33.9% | 0.03% | -28.9% |
| Q2 2018 | $1,297,000 | +8.8% | 1,476,000 | 0.0% | 0.04% | -5.0% |
| Q1 2018 | $1,192,000 | +0.8% | 1,476,000 | 0.0% | 0.04% | 0.0% |
| Q4 2017 | $1,183,000 | +2.4% | 1,476,000 | 0.0% | 0.04% | -2.4% |
| Q3 2017 | $1,155,000 | -19.7% | 1,476,000 | 0.0% | 0.04% | -24.1% |
| Q2 2017 | $1,439,000 | +3.9% | 1,476,000 | 0.0% | 0.05% | +1.9% |
| Q1 2017 | $1,385,000 | +4.4% | 1,476,000 | 0.0% | 0.05% | +6.0% |
| Q4 2016 | $1,326,000 | -19.9% | 1,476,000 | -0.2% | 0.05% | -15.3% |
| Q3 2016 | $1,656,000 | – | 1,479,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Silver Point Capital L.P. | 57,420,000 | $44,527,000 | 5.17% |
| Birch Grove Capital LP | 10,003,000 | $7,934,000 | 4.14% |
| PenderFund Capital Management Ltd. | 9,605,000 | $9,491,000 | 2.41% |
| Context Capital Management, LLC | 9,887,000 | $7,671,000 | 1.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 57,791,000 | $45,738,000 | 0.90% |
| DeepCurrents Investment Group LLC | 35,892,000 | $27,953,000 | 0.74% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 22,977,000 | $18,267,000 | 0.70% |
| WHITEBOX ADVISORS LLC | 23,150,000 | $17,847,000 | 0.56% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 27,397,000 | $21,720,000 | 0.46% |
| OAKTREE CAPITAL MANAGEMENT LP | 19,435,000 | $15,079,000 | 0.26% |